Article Information
History
- September 27, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Emma Rezel-Potts, PhD1,2,*,
- Abdel Douiri, PhD1,2,3,
- Phil J. Chowienczyk, FRCP4 and
- Martin C. Gulliford, FFPH1,2,3
- 1King’s College London, School of Population Health and Environmental Sciences, London, UK
- 2National Institute for Health Research Biomedical Research Centre (BRC), Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK
- 3National Institute for Health Research Applied Research Collaboration (ARC) South London, Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK
- 4King’s College London, British Heart Foundation Centre, London, UK
- ↵*Correspondence: Dr Emma Rezel-Potts, Addison House, Guy’s Campus, King’s College London, London SE1 1UL, Email: emma.rezel-potts{at}kcl.ac.uk, Tel: 0207 848 6631, Fax: 0207 848 6620
Posted September 27, 2020.
Antihypertensive Medications and COVID-19 Diagnosis and Mortality: Population-based Case-Control Analysis in the United Kingdom
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos